This job is closed
Applications are no longer available for this announcement. Explore current related opportunities below.
Job description
Research Faculty - IM Medical Oncology (Open Rank/Track Faculty)
Department: Medicine | IM Medical Oncology
Tenure faculty (regardless of rank) - persons with the titles of professor, associate professor, assistant professor and instructor who serve on appointments totaling 50% or more service to the university and who are eligible for tenure or who have obtained tenure. Duties and responsibilities are assigned in accordance with the workload guidelines laid out in the pattern of administration of each faculty member's tenure initiation unit (TIU) and, as appropriate, regional campus; obligations will include research, service and/or teaching or clinical practice. These faculty will have earned doctorate or other terminal degree in the relevant field of study or possession of equivalent experience.
Additional Information:
Managing Director of Antibody Therapeutics (Research-Track Associate Professor) – Pelotonia Institute for Immuno-Oncology and Division of Medical Oncology
Position Overview
The Pelotonia Institute for Immuno-Oncology (PIIO) is a comprehensive bench-to-bedside research initiative focused on harnessing the body's immune system to fight cancer at all levels. Established by a pledge of more than $100 million from Pelotonia, the PIIO represents Ohio State's commitment to grow the exciting area of immuno-oncology. Led by founding director Zihai Li, MD, PhD, the PIIO builds upon a rich portfolio of active investigator-initiated IO clinical trials being conducted at the OSUCCC – James.
The Division of Medical Oncology, led by Christian Rolfo, MD, PhD, MBA, is a nationally recognized leader in cancer research, clinical care, and physician-scientist training within the Department of Internal Medicine at The Ohio State University College of Medicine. The Division's mission is to revolutionize cancer care by advancing cutting-edge research across all tumor types, fostering a culture of collaboration and clinical excellence, recruiting and empowering top-tier talent and seamlessly translating discoveries from bench to bedside.
The PIIO and the Division of Medical Oncology (MedOnc) invite applications for a research-track associate professor position to serve as managing director of a new Antibody Therapeutics Program. We seek an outstanding scientist with a distinguished track record of research in antibody discovery, engineering, and development with a focus on cancer immunotherapy.
Education and Experience Requirements
Applicants must hold an MD, DO, PhD, MD/PhD, or equivalent doctoral degree. Candidates should have a strong record of scholarly achievement, including peer-reviewed publications and evidence of an established or emerging independent research program with a demonstrated ability to obtain extramural funding. Applicants should have experience working in collaborative, multidisciplinary research environments and a commitment to mentoring trainees and junior investigators. Appointment at the rank of Research-Track Associate Professor will be commensurate with the candidate's qualifications, experience, and academic accomplishments.
Ohio State provides access to a depth and breadth of opportunities and resources. Starting your first day, Ohio State offers you a comprehensive benefits package.
How to Apply To be considered, please submit your application electronically via Workday. Application materials must include cover letter and Curriculum Vita (CV). All inquiries and nominations should be directed in confidence to: Anna Godwin, Research Faculty Recruitment,
Required
Cover letter Curriculum Vita (CV)
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute expanded in December 2014 to become the 3rd largest cancer hospital in the U.S. The extraordinary success of this new 398 -bed state-of-the-art hospital has resulted in remarkable clinical growth and robust research portfolio.
NCI-designated Comprehensive Cancer Center since 1976
One of only 11 freestanding cancer hospitals in the U.S.
Magnet® designation
One of only four cancer centers funded by the NCI to conduct Phase I and II cancer clinical trials
Founding member of the National Comprehensive Cancer Network (NCCN)
Founding member of the Oncology Research Information Exchange Network (ORIEN)
Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract
Consistently ranked as one of America's Best Cancer Hospitals by U.S. News & World Report
Financially-secure program with strong philanthropic and community support
The PIIO is a comprehensive bench-to-bedside research initiative focused on harnessing the body's immune system to fight cancer at all levels. Launched in July 2019 as part of a $102 Million pledge from Pelotonia, the PIIO represents Ohio State's commitment to grow the exciting area of immuno-oncology. Led by founding director and renowned immunologist Zihai Li, MD, PhD, the PIIO builds upon a rich portfolio of active investigator-initiated IO clinical trials being conducted at the OSUCCC – James.
Research in the PIIO centers on Systems IO (a systems-wide strategy to study the anti-cancer immune response holistically to discover the next IO breakthroughs and create effective cancer immunotherapies) and Translational IO (where we turn discoveries into new or improved cancer treatments and broaden the indications and patient populations that can be treated with cellular therapy). Our Immune Monitoring and Discovery Platform (IMDP) supports each center, providing comprehensive cell-based and molecule-based immunoassay services to support basic, translational, and clinical IO studies. The PIIO's Immuno-Oncology Informatics Group (IOIG) provides data analytics for flow and mass cytometry, bulk and single-cell RNA-Seq, spatial transcriptomics and imaging, neoantigen discovery, and more.
Ohio State is a top-20 public university, and its Ohio State Wexner Medical Center is one of America's leading academic health centers. Eligible Ohio State employees receive comprehensive benefits packages, including medical, dental and vision insurance, tuition assistance for employees and their dependents, and state or alternative retirement options with competitive employer contributions.
Grounded in Ohio State University's Shared Values, our university community welcomes differences, encourages open-minded exploration and courageous thinking, and upholds freedom of expression.
Ohio State is a dynamic community where opportunity thrives, and individuals transform themselves and their world. Positions are available in countless fields and specialties. Become a Buckeye and contribute to an incredible legacy that serves to guide our future and shape a better tomorrow.
The Ohio State University is committed to enhancing academic excellence. Recruiting, supporting, and retaining faculty of the highest caliber is a core component of this commitment. The Office of Academic Affairs (OAA) has established central resources to focus on offering support to new and prospective faculty and their loved ones. Service offerings include dual career partner consultation, potential employer and/or employment opportunity identification, consultation and resources related to relocation, as well as identifying opportunities to engage on campus and in the surrounding community. While employment opportunities are not guaranteed, resources and consultation are available. More information about dual career and faculty recruitment can be found here.
In addition to being responsive to dual-career opportunities, we strongly promote work-life balance to support our community members through a suite of institutionalized policies. Ohio State is a member of the Michigan, Ohio, Western Pennsylvania & West Virginia HERC.
Location:
Biomedical Research Tower (0112)
Position Type:
Regular
Scheduled Hours:
40
Shift:
The Ohio State University believes in diversity in people and ideas. What Ohio State does matters. And how we do it matters. When we are at our best, we make a real difference to people. Our size, breadth, geography, history and standard of excellence position us to drive the future of higher education. We believe that the university should be a place where people can work and learn together in a safe environment, free of violence, harassment, discrimination, exploitation, or intimidation. As such, finalists for any faculty position that carries tenure must sign an authorization and disclosure form, which will allow current or prior employer(s) to share information to the University regarding any findings of employment-related misconduct or disciplinary proceedings against a candidate and/or any pending investigations related to alleged misconduct. Such information shall include findings and pending investigations with respect to sexual harassment, violence, or harassment; research misconduct; financial fraud or misconduct; foreign influence violations, grant misuse or misconduct; and/or any other type of finding or pending investigation relating to a candidate's employer's policies and rules governing faculty conduct that may reasonably be expected to affect a candidate's appointment. If the University becomes aware of any past finding of misconduct or pending investigations that were not disclosed, Ohio State will treat that as a serious omission and reserves the right to rescind an offer or terminate employment.
Final candidates are subject to successful completion of a background
Worksite address
columbus, OH, 43224, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.